Your browser doesn't support javascript.
loading
Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem.
Arneric, Stephen P; Cedarbaum, Jesse M; Khozin, Sean; Papapetropoulos, Spyros; Hill, Derek L; Ropacki, Michael; Rhodes, Jane; Dacks, Penny A; Hudson, Lynn D; Gordon, Mark Forrest; Kern, Volker D; Romero, Klaus; Vradenburg, George; Au, Rhoda; Karlin, Daniel R; Facheris, Maurizio F; Fitzer-Attas, Cheryl J; Vitolo, Ottavio V; Wang, Jian; Miller, Bradley M; Kaye, Jeffrey A.
Affiliation
  • Arneric SP; Critical Path Institute, Tucson, Arizona, USA.
  • Cedarbaum JM; Biogen, Cambridge, Massachusetts, USA.
  • Khozin S; Food and Drug Administration, Bethesda, Maryland, USA.
  • Papapetropoulos S; TEVA, Cambridge, Massachusetts, USA. Present address: Massachusetts General Hospital, Harvard, Boston, Massachusetts, USA.
  • Hill DL; IXICO, London, UK.
  • Ropacki M; Loma Linda University, Loma Linda, California, USA.
  • Rhodes J; Biogen, Cambridge, Massachusetts, USA.
  • Dacks PA; Alzheimer's Drug Discovery Foundation, New York, New York, USA. Present address: American Epilepsy Association, Chicago, Illinois, USA.
  • Hudson LD; Critical Path Institute, Tucson, Arizona, USA.
  • Gordon MF; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA. Present address: TEVA, Malvern, Pennsylvania, USA.
  • Kern VD; Critical Path Institute, Tucson, Arizona, USA.
  • Romero K; Critical Path Institute, Tucson, Arizona, USA.
  • Vradenburg G; UsAgainstAlzheimer's, Washington, DC, USA.
  • Au R; Boston University, Boston, Massachusetts, USA.
  • Karlin DR; Pfizer, Boston, Massachusetts, USA.
  • Facheris MF; AbbVie, North Chicago, Illinois, USA.
  • Fitzer-Attas CJ; CHDI Foundation, Princeton, New Jersey, USA.
  • Vitolo OV; Pfizer, Boston, Massachusetts, USA. Present address: Homology Medicines, Boston, Massachusetts, USA.
  • Wang J; Eli Lilly &Company, Indianapolis, Indianapolis, USA.
  • Miller BM; Eli Lilly &Company, Indianapolis, Indianapolis, USA.
  • Kaye JA; Oregon Health &Science University, Portland, Oregon, USA.
Nat Rev Drug Discov ; 16(10): 736, 2017 10.
Article in En | MEDLINE | ID: mdl-28935908
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Drug Discovery / Monitoring, Physiologic Limits: Humans Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Drug Discovery / Monitoring, Physiologic Limits: Humans Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido